Literature DB >> 29705243

A kindred with mutant IKAROS and autoimmunity.

Erika Van Nieuwenhove1, Josselyn E Garcia-Perez2, Christine Helsen3, Princess D Rodriguez4, Pauline A van Schouwenburg5, James Dooley2, Susan Schlenner2, Mirjam van der Burg5, Els Verhoeyen6, Rik Gijsbers7, Seth Frietze4, Hilde Schjerven8, Isabelle Meyts9, Frank Claessens3, Stephanie Humblet-Baron2, Carine Wouters10, Adrian Liston11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29705243      PMCID： PMC6541477          DOI： 10.1016/j.jaci.2018.04.008

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

1.  Ikaros limits follicular B cell activation by regulating B cell receptor signaling pathways.

Authors:  Beate Heizmann; MacLean Sellars; Alejandra Macias-Garcia; Susan Chan; Philippe Kastner
Journal:  Biochem Biophys Res Commun       Date:  2016-01-14       Impact factor: 3.575

2.  Expression of a non-DNA-binding Ikaros isoform exclusively in B cells leads to autoimmunity but not leukemogenesis.

Authors:  Heather Wojcik; Erin Griffiths; Sarah Staggs; James Hagman; Susan Winandy
Journal:  Eur J Immunol       Date:  2007-04       Impact factor: 5.532

3.  Hyperresponsive B cells in CD22-deficient mice.

Authors:  T L O'Keefe; G T Williams; S L Davies; M S Neuberger
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

Review 4.  The role of the Ikaros gene in lymphocyte development and homeostasis.

Authors:  K Georgopoulos; S Winandy; N Avitahl
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

5.  HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.

Authors:  B Dörken; G Moldenhauer; A Pezzutto; R Schwartz; A Feller; S Kiesel; L M Nadler
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

6.  Loss of B Cells in Patients with Heterozygous Mutations in IKAROS.

Authors:  H S Kuehn; B Boisson; M E Conley; S D Rosenzweig; C Cunningham-Rundles; J Reichenbach; A Stray-Pedersen; E W Gelfand; P Maffucci; K R Pierce; J K Abbott; K V Voelkerding; S T South; N H Augustine; J S Bush; W K Dolen; B B Wray; Y Itan; A Cobat; H S Sorte; S Ganesan; S Prader; T B Martins; M G Lawrence; J S Orange; K R Calvo; J E Niemela; J-L Casanova; T A Fleisher; H R Hill; A Kumánovics
Journal:  N Engl J Med       Date:  2016-03-17       Impact factor: 91.245

7.  Ikaros is critical for B cell differentiation and function.

Authors:  Peggy Kirstetter; Mireille Thomas; Andrée Dierich; Philippe Kastner; Susan Chan
Journal:  Eur J Immunol       Date:  2002-03       Impact factor: 5.532

8.  Abnormal hematopoiesis and autoimmunity in human subjects with germline IKZF1 mutations.

Authors:  Akihiro Hoshino; Satoshi Okada; Kenichi Yoshida; Naonori Nishida; Yusuke Okuno; Hiroo Ueno; Motoi Yamashita; Tsubasa Okano; Miyuki Tsumura; Shiho Nishimura; Sonoko Sakata; Masao Kobayashi; Haruna Nakamura; Junji Kamizono; Kanako Mitsui-Sekinaka; Takuya Ichimura; Shouichi Ohga; Yozo Nakazawa; Masatoshi Takagi; Kohsuke Imai; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Seishi Ogawa; Seiji Kojima; Shigeaki Nonoyama; Tomohiro Morio; Hirokazu Kanegane
Journal:  J Allergy Clin Immunol       Date:  2016-12-06       Impact factor: 10.793

9.  A novel IKAROS haploinsufficiency kindred with unexpectedly late and variable B-cell maturation defects.

Authors:  Delfien J Bogaert; Hye Sun Kuehn; Carolien Bonroy; Katherine R Calvo; Joke Dehoorne; Arnaud V Vanlander; Marieke De Bruyne; Urszula Cytlak; Venetia Bigley; Frans De Baets; Elfride De Baere; Sergio D Rosenzweig; Filomeen Haerynck; Melissa Dullaers
Journal:  J Allergy Clin Immunol       Date:  2017-09-18       Impact factor: 10.793
  9 in total
  21 in total

1.  IKZF1 Loss-of-Function Variant Causes Autoimmunity and Severe Familial Antiphospholipid Syndrome.

Authors:  Yannick Dieudonné; Aurélien Guffroy; Olivier Vollmer; Raphael Carapito; Anne-Sophie Korganow
Journal:  J Clin Immunol       Date:  2019-05-14       Impact factor: 8.317

2.  Systemic lupus erythematosus as a genetic disease.

Authors:  Isaac T W Harley; Amr H Sawalha
Journal:  Clin Immunol       Date:  2022-02-09       Impact factor: 10.190

Review 3.  IKAROS Family Zinc Finger 1-Associated Diseases in Primary Immunodeficiency Patients.

Authors:  Cristiane J Nunes-Santos; Hye Sun Kuehn; Sergio D Rosenzweig
Journal:  Immunol Allergy Clin North Am       Date:  2020-08       Impact factor: 3.479

4.  Ikaros prevents autoimmunity by controlling anergy and Toll-like receptor signaling in B cells.

Authors:  Tanja A Schwickert; Hiromi Tagoh; Karina Schindler; Maria Fischer; Markus Jaritz; Meinrad Busslinger
Journal:  Nat Immunol       Date:  2019-10-07       Impact factor: 25.606

5.  Familial Immune Thrombocytopenia Associated With a Novel Variant in IKZF1.

Authors:  Panida Sriaroon; Yenhui Chang; Boglarka Ujhazi; Krisztian Csomos; Hemant R Joshi; Qin Zhou; Devin W Close; Jolan E Walter; Attila Kumánovics
Journal:  Front Pediatr       Date:  2019-04-24       Impact factor: 3.418

Review 6.  Primary Immunodeficiency and Cancer Predisposition Revisited: Embedding Two Closely Related Concepts Into an Integrative Conceptual Framework.

Authors:  Oskar A Haas
Journal:  Front Immunol       Date:  2019-02-12       Impact factor: 7.561

7.  A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROS.

Authors:  Hye Sun Kuehn; Kazuki Okuyama; Motoi Yamashita; Satoshi Okada; Yuzaburo Inoue; Noriko Mitsuiki; Kohsuke Imai; Masatoshi Takagi; Hirokazu Kanegane; Masahiro Takeuchi; Naoki Shimojo; Miyuki Tsumura; Aditya K Padhi; Kam Y J Zhang; Bertrand Boisson; Jean-Laurent Casanova; Osamu Ohara; Sergio D Rosenzweig; Ichiro Taniuchi; Tomohiro Morio
Journal:  Nat Immunol       Date:  2021-06-21       Impact factor: 25.606

Review 8.  IKAROS-Associated Diseases in 2020: Genotypes, Phenotypes, and Outcomes in Primary Immune Deficiency/Inborn Errors of Immunity.

Authors:  Hye Sun Kuehn; Cristiane J Nunes-Santos; Sergio D Rosenzweig
Journal:  J Clin Immunol       Date:  2021-01-03       Impact factor: 8.317

Review 9.  Germline IKZF1 mutations and their impact on immunity: IKAROS-associated diseases and pathophysiology.

Authors:  Hye Sun Kuehn; Cristiane J Nunes-Santos; Sergio D Rosenzweig
Journal:  Expert Rev Clin Immunol       Date:  2021-03-19       Impact factor: 4.473

10.  Germline IKAROS dimerization haploinsufficiency causes hematologic cytopenias and malignancies.

Authors:  Hye Sun Kuehn; Julie E Niemela; Jennifer Stoddard; Sara Ciullini Mannurita; Tala Shahin; Shubham Goel; Mary Hintermeyer; Raul Jimenez Heredia; Mary Garofalo; Laura Lucas; Smriti Singh; Annalisa Tondo; Zachary Jacobs; William A Gahl; Sylvain Latour; James Verbsky; John Routes; Charlotte Cunningham-Rundles; Kaan Boztug; Eleonora Gambineri; Thomas A Fleisher; Shanmuganathan Chandrakasan; Sergio D Rosenzweig
Journal:  Blood       Date:  2021-01-21       Impact factor: 25.476
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.